These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Use of a vaccine for prevention of Pseudomonas aeruginosa infection of burn wounds in mice]. Grochowski J, Bilinska M, Stankiewicz D, Arkusiewicz E. Pol Przegl Chir; 1979 Jun; 51(6):623-7. PubMed ID: 116210 [No Abstract] [Full Text] [Related]
25. Assessment of the effectiveness of antipseudomonas biological management in the control of infection in burn patients. Gonzáles Ayala SE, Daroda M, Villa J, Cecchini E, Vich J. Panminerva Med; 1983 Jun; 25(3):203-8. PubMed ID: 6422426 [No Abstract] [Full Text] [Related]
27. Efficacy of antibodies against the N-terminal of Pseudomonas aeruginosa flagellin for treating infections in a murine burn wound model. Barnea Y, Carmeli Y, Gur E, Kuzmenko B, Gat A, Neville LF, Eren R, Dagan S, Navon-Venezia S. Plast Reconstr Surg; 2006 Jun; 117(7):2284-91. PubMed ID: 16772930 [Abstract] [Full Text] [Related]
28. The role of prophylactic antibiotics in burn care. Larkin JM, Moylan JA. Am Surg; 1976 Apr; 42(4):247-50. PubMed ID: 773229 [No Abstract] [Full Text] [Related]
29. The behavior of mafenide acetate as a basis for its clinical use. Harrison HN, Bales H, Jacoby F. Arch Surg; 1971 Oct; 103(4):449-53. PubMed ID: 5094550 [No Abstract] [Full Text] [Related]
33. [Bacteriological and clinical studies of the use of sulfamylon in the treatment of burns]. Brudzyńska-Charewicz S, Zietkiewicz W, Nasilowski W, Serafińska D, Bukowska D, Rudowski W. Pol Przegl Chir; 1972 May; 44(5):783-90. PubMed ID: 4625104 [No Abstract] [Full Text] [Related]